Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study (Q39250004)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study |
scientific article |
Statements
1 reference
Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study (English)
1 reference
Jean Schoenen
1 reference
Hans-Christoph Diener
1 reference
Markus Färkkilä
1 reference
Gilles Géraud
1 reference
Miguel Láinez
1 reference
Nadja Harner
1 reference
Alison Pilgrim
1 reference
Uwe Reuter
1 reference
COL MIG-202 study group
1 reference
28 March 2012
1 reference
1 reference
11
1 reference
5
1 reference
405-413
1 reference
Identifiers
1 reference
1 reference